Barings LLC Abb Vie Inc. Transaction History

Barings LLC

$4.06 Billion
Q3 2024

A detailed history of Barings LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Barings LLC holds 1,039 shares of ABBV stock, worth $187,020. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,039

Holding current value

$187,020

% of portfolio

0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $170,229 - $207,103	1,039 New	1,039 $205,000
Q2 2023 Aug 08, 2023	BUY	$132.51 - $164.9 $197,572 - $245,865	1,491 New	1,491 $200,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.55 Million - $1.78 Million	-11,581 Reduced 80.99%	2,719 $365,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $449,879 - $571,944	3,269 Added 29.63%	14,300 $2.19 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $115,086 - $142,790	-872 Reduced 7.33%	11,031 $1.79 Million
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $242,362 - $306,658	-2,256 Reduced 15.93%	11,903 $1.61 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $589,562 - $669,241	5,541 Added 64.3%	14,159 $1.53 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $123,726 - $137,838	-1,176 Reduced 12.01%	8,618 $970,000
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $64,858 - $71,401	-634 Reduced 6.08%	9,794 $1.06 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $9.53 Million - $12.9 Million	-118,363 Reduced 91.9%	10,428 $1.12 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $1.16 Million - $1.36 Million	13,479 Added 11.69%	128,791 $11.3 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $1,741 - $2,640	27 Added 0.02%	115,312 $8.79 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.04 Million - $1.3 Million	14,386 Added 14.26%	115,285 $10.2 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $47,864 - $57,547	760 Added 0.76%	100,899 $7.64 Million
Q2 2019 Aug 12, 2019	SELL	$65.7 - $83.98 $2.35 Million - $3 Million	-35,696 Reduced 26.28%	100,139 $7.28 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $698,271 - $821,831	9,052 Added 7.14%	135,835 $10.9 Million
Q4 2018 Feb 07, 2019	SELL	$77.85 - $96.01 $82,443 - $101,674	-1,059 Reduced 0.83%	126,783 $11.7 Million
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $4.55 Million - $5.06 Million	-51,170 Reduced 28.58%	127,842 $12.1 Million
Q2 2018 Aug 03, 2018	BUY	$89.78 - $106.23 $2.08 Million - $2.46 Million	23,160 Added 14.86%	179,012 $16.6 Million
Q1 2018 May 04, 2018	BUY	$92.01 - $123.21 $1.02 Million - $1.36 Million	11,043 Added 7.63%	155,852 $14.8 Million
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $2.44 Million - $2.68 Million	27,300 Added 23.23%	144,809 $14 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-47,100 Reduced 28.61%	117,509 $8.52 Million
Q2 2017 Aug 14, 2017	BUY	N/A	164,609	164,609 $0

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account